Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Moderna Inc.

Start price
Target price
Perf. (%)
€268.00
19.12.21
€135.00
19.12.22
-48.51%
19.09.22

foxx1one 
19.12.21 60%
sell
Bitcoin

Start price
Target price
Perf. (%)
€41,452
18.12.21
€32,000
18.12.22
-54.53%
19.09.22

foxx1one 
18.12.21 100%
sell
Heat Biologics Inc.

Start price
Target price
Perf. (%)
€5.30
18.09.21
-
18.09.22
-63.56%
19.09.22

Risky Investment
High risks for its business
Dependend from few customers or products
Shooter 
18.09.21 50%
buy
Blackrock I-br Adv.eu. Equ.

Start price
Target price
Perf. (%)
€126.55
18.09.21
-
18.09.22
-2.66%
19.09.22

Could be worthwhile Investment >10% per year
melinda 
18.09.21 50%
buy
TCR2 Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.38
09.09.22
-
09.09.23
-6.96%
18.09.22

Risky Investment
michaelkr 
09.09.22 50%
buy
Leap Therapeutics Inc.

Start price
Target price
Perf. (%)
€12.96
13.09.22
-
13.09.23
-17.60%
18.09.22

Could be worthwhile Investment >10% per year
michaelkr 
13.09.22 50%
buy
Tilray Inc

Start price
Target price
Perf. (%)
€3.27
12.06.22
-
12.06.23
-0.89%
18.09.22

Could be very worthwhile Investment >20% year
thomasw 
12.06.22 50%
buy
Puma Biotechnology Inc.

Start price
Target price
Perf. (%)
€2.63
04.09.22
-
04.09.23
-6.99%
18.09.22

Could be worthwhile Investment >10% per year
thomasw 
04.09.22 50%
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€2.62
13.09.22
-
13.09.23
-37.10%
17.09.22

Could be very worthwhile Investment >20% year
bundfuture 
13.09.22 50%
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.62
14.09.22
-
14.09.23
1.70%
17.09.22

Risky Investment
Vassago1 
14.09.22 50%
buy
AMTD IDEA Group ADR

Start price
Target price
Perf. (%)
€3.60
16.09.22
-
16.09.23
-1.11%
17.09.22

Risky Investment
Vassago1 
16.09.22 50%
sell
Volkswagen AG VZO

Start price
Target price
Perf. (%)
€160.24
30.11.21
€130.00
30.11.22
-7.56%
17.09.22

Well known brand
Risky Investment
overvalued
Deficits in Management
Snowman 
30.11.21 50%
sell
Farfetch Ltd

Start price
Target price
Perf. (%)
€9.52
04.09.22
€5.00
04.09.23
10.78%
17.09.22

Revenue decline/stagnation expected
Very low/no dividend yield expected
very negative Cash Flow expected
High risks in the balance sheet
Ruckelsbuckel 
04.09.22 60%
sell
First Hydrogen Corp.

Start price
Target price
Perf. (%)
€3.82
04.09.22
€1.00
04.09.23
-7.33%
17.09.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
overvalued
Marianka 
04.09.22 50%
sell
ShiftPixy Inc.

Start price
Target price
Perf. (%)
€31.30
10.09.22
€4.00
10.09.23
-37.16%
17.09.22

Revenue decline/stagnation expected
Lower EBIT Margin than peer group
Very low/no dividend yield expected
very negative Cash Flow expected
Marianka 
10.09.22 50%
sell
Toughbuilt Industries Inc.

Start price
Target price
Perf. (%)
€2.77
13.09.22
€1.00
13.09.23
-19.91%
17.09.22

Could be worthwhile Investment >10% per year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Marianka 
13.09.22 40%
sell
Quhuo Ltd. ADR

Start price
Target price
Perf. (%)
€2.90
13.09.22
€1.00
13.09.23
-22.07%
17.09.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Marianka 
13.09.22 50%
sell
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€26.40
15.09.22
€8.00
15.09.23
-1.52%
17.09.22

Revenue growth >5% per year expected
Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Marianka 
15.09.22 30%
sell
Atlanticus Holdings Corp

Start price
Target price
Perf. (%)
€25.20
04.09.22
€11.00
04.09.23
-
17.09.22

Revenue growth >5% per year expected
Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
dimontalban 
04.09.22 0%
buy
Allakos Inc

Start price
Target price
Perf. (%)
€4.72
04.09.22
€12.00
04.09.23
-2.53%
17.09.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
dimontalban 
04.09.22 70%
sell
ShiftPixy Inc.

Start price
Target price
Perf. (%)
€31.30
10.09.22
€11.00
10.09.23
-37.16%
17.09.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
dimontalban 
10.09.22 60%
sell
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€26.40
15.09.22
€11.00
15.09.23
-1.52%
17.09.22

Differentiated customer and product portfolio
High valuation
High risks in the balance sheet
Increased challenges to pay loans and raise capital
dimontalban 
15.09.22 50%
sell
Rand Mining Ltd

Start price
Target price
Perf. (%)
€0.90
16.09.22
€0.000
16.09.23
-
17.09.22

High valuation
Junk rating
ROE lower than 10% per year
Few uniques
dimontalban 
16.09.22 50%
buy
Ethereum

Start price
Target price
Perf. (%)
€2,898.3
17.09.22
€1,500.0
17.09.23
-
17.09.22

Traumtanz 
17.09.22 50%
buy
Heidelberger Druckmaschinen AG

Start price
Target price
Perf. (%)
€1.62
17.08.22
€2.20
17.09.22
-19.77%
17.09.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
BE69 
17.08.22 50%